NASDAQ:EWTX | Profit Breakdown | Edgewise Therapeutics, Inc.

Complete filed revenue-to-profit bridge showing gross profit, operating income, pre-tax income and net income.

Available history
2020-03-31 to 2026-06-30
Data captured

Historical Profit Breakdown

DateRevenueGross profitOperating incomePre-tax incomeNet income
2026-06-30-$61.94M-$57.33M
2026-03-31-$54.12M-$49.01M
2025-12-31-$55.98M-$50.22M
2025-09-30-$46.86M-$40.67M
2025-06-30-$42.61M-$36.12M
2025-03-31-$45.96M-$40.8M
2024-12-31-$45.54M-$39.66M
2024-09-30-$40.43M-$34.13M
2024-06-30-$38.11M-$31.5M
2024-03-31-$34.75M-$28.53M
2023-12-31-$33.86M-$30.14M
2023-09-30-$29.45M-$25.71M
2023-06-30-$25.34M-$21.47M
2023-03-31-$25.7M-$22.84M
2022-12-31-$22.08M-$19.42M
2022-09-30-$18.26M-$17.5M
2022-06-30-$16.49M-$16.07M
2022-03-31-$14.83M-$14.66M
2021-12-31-$12.82M-$12.7M
2021-09-30-$13.08M-$12.95M
2021-06-30-$10.46M-$10.35M
2021-03-31-$6.86M-$6.82M
2020-12-31-$6.34M-$6.34M
2020-09-30-$3.64M-$3.64M
2020-06-30-$3.96M-$3.95M
2020-03-31-$3.25M-$3.19M

Annual Profit Breakdown

DateRevenueGross profitOperating incomePre-tax incomeNet income
2025-12-31-$191.41M-$167.8M-$167.8M
2024-12-31-$158.83M-$133.8M-$133.81M
2023-12-31-$114.36M-$100.2M-$100.16M
2022-12-31-$71.66M-$67.64M
2021-12-31-$43.22M-$42.81M
2020-12-31-$17.19M-$17.12M